Cargando…

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity

CONTEXT: Shengmai injection (SMI) has been used to treat heart failure. OBJECTIVE: This study determines the molecular mechanisms of SMI against cardiotoxicity caused by doxorubicin (DOX). MATERIALS AND METHODS: In vivo, DOX (15 mg/kg) was intraperitoneally injected in model, Dex (dexrazoxane), SMI-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Peng, Gao, Ge, Zhao, Chun-chun, Li, Jing-ya, Peng, Jian-fei, Wang, Shu-shu, Song, Rui, Shi, Hui, Wang, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933025/ https://www.ncbi.nlm.nih.gov/pubmed/35298357 http://dx.doi.org/10.1080/13880209.2022.2046801

Ejemplares similares

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
por: Sun, Jing, et al.
Publicado: (2013)

A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
por: Chen, Yu, et al.
Publicado: (2015)

In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
por: Chen, Chih-Tai, et al.
Publicado: (2015)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023)

Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
por: Li, Lin, et al.
Publicado: (2020)

Total Flavonoids from Clinopodium chinense (Benth.) O. Ktze Protect against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo
por: Chen, Rong Chang, et al.
Publicado: (2015)

Shengmai Injection Improved Doxorubicin-Induced Cardiomyopathy by Alleviating Myocardial Endoplasmic Reticulum Stress and Caspase-12 Dependent Apoptosis
por: Chen, Yu, et al.
Publicado: (2015)

The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase
por: Jiang, Li-Peng, et al.
Publicado: (2014)

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
por: Ulusan, Sebahat, et al.
Publicado: (2023)

Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo
por: Wang, Hongbo, et al.
Publicado: (2012)

Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity
por: Wang, Yuewen, et al.
Publicado: (2019)

Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity
por: Xi, Lei, et al.
Publicado: (2011)

Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro
por: Niu, Zhenchao, et al.
Publicado: (2022)

Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy
por: Li, Weili, et al.
Publicado: (2022)

Shengmai injection combined with conventional therapy in treating Adriamycin-related cardiotoxicity: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Liu, Lanchun, et al.
Publicado: (2020)

Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators
por: Zhang, Sheng, et al.
Publicado: (2019)

Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation
por: Lu, Jing, et al.
Publicado: (2019)

Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice
por: Hu, Xiaoping, et al.
Publicado: (2020)

The Protective Effect of Citronellol against Doxorubicin-Induced Cardiotoxicity in Rats
por: Munir, Sania, et al.
Publicado: (2023)

In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review
por: Zhang, Qian, et al.
Publicado: (2022)

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2018)

Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension: A Systematic Review and Meta-Analysis
por: Chen, Chao-yang, et al.
Publicado: (2013)

Activation of the MET receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro
por: Gallo, Simona, et al.
Publicado: (2020)

Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
por: Sun, Xi-Peng, et al.
Publicado: (2017)

Investigation of the Mechanism of Shengmai Injection on Sepsis by Network Pharmacology Approaches
por: Lu, Juan, et al.
Publicado: (2020)

Natural Polysaccharide β-Glucan Protects against Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress
por: Wang, Xuan, et al.
Publicado: (2022)

Fucoidan Protects against Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Preventing Mitochondrial Function Injury
por: Ji, Yuting, et al.
Publicado: (2022)

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity
por: Gu, Jun, et al.
Publicado: (2015)

The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats
por: Rašković, Aleksandar, et al.
Publicado: (2011)

Protective effect of Vernonia amygdalina Delile against doxorubicin-induced cardiotoxicity
por: Syahputra, R.A., et al.
Publicado: (2021)

Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2019)

Sugemule-3 Protects against Isoprenaline-induced Cardiotoxicity In vitro
por: Wang, Yu, et al.
Publicado: (2017)

Mulberrin Confers Protection against Doxorubicin-Induced Cardiotoxicity via Regulating AKT Signaling Pathways in Mice
por: Ye, Peng, et al.
Publicado: (2022)

Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
por: Wang, Panxia, et al.
Publicado: (2021)

Shengmai injection inhibits palmitic acid-induced myocardial cell inflammatory death via regulating NLRP3 inflammasome activation
por: Yin, Gang, et al.
Publicado: (2023)

Efficacy and Safety of Shengmai Injection for Chronic Heart Failure: A Systematic Review of Randomized Controlled Trials
por: Wang, Yanping, et al.
Publicado: (2020)

Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
por: Dorostkar, Hamidreza, et al.
Publicado: (2023)

Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
por: Rephaeli, A, et al.
Publicado: (2007)

Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study
por: QuanJun, Yang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4hanlml9f46ahbodng3b0h3mu1